US · USD
CVS
CVS Health Corp
- Day's range
- US$84.23 – US$86.26
- Day's volume
- US$267.1m
- 52-week range
- US$69.04 – US$109.92
Follow CVS on Fuolio
See how CVS weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountCVS in numbers
- Market cap
- US$108.8bn
- P/E
- 22.28
- P/B
- 1.37
- Dividend yield (12m)
- 3.12%
The 12-month dividend yield of CVS is 3.12%, below its 5-year average of 3.33%.
CVS price history
CVS risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +11.45% | +37.12% | +11.88% |
| Volatility (annualised) | 31.80% | 36.92% | 31.97% |
| Largest drawdown | -18.56% | -41.89% | -53.90% |
| Positive months | 7/12 | 19/36 | 28/60 |
How much did investing in CVS return?
US$1,000.00 invested on 01/10/2021 would be worth US$1,119.95 today.
- Value today in CVS
- US$1,119.95
- Return over the period
- +11.99%
- Return per year
- +2.29%
- In the S&P 500
- US$1,664.67
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
CVS fundamentals
Valuation
- P/E22.28
- P/B1.37
- EV/EBITDA8.49
- EV/EBIT13.12
- EV/Revenue0.26
- P/EBIT13.12
- P/S0.26
- P/OCF7.36
- P/FCF9.25
- Earnings yield7.62%
- PEG ratio—
- Earnings per shareUS$3.82
- Book value per shareUS$62.32
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio0.87
- Quick ratio0.66
- Cash ratio0.16
Efficiency
- Gross margin44.49%
- EBITDA margin3.09%
- Operating margin2.00%
- Net margin1.18%
- Asset turnover1.64
Profitability
- ROE6.14%
- ROA1.93%
- ROIC8.78%
- Payout69.57%
Growth
- Revenue CAGR (5 years)8.32%
- Earnings CAGR (5 years)-7.45%
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
What is CVS's fair price?
Two classic value formulas, with today's numbers. The current price is US$85.20.
- Graham's fair price
- US$73.22
- 14.06% below the price
√(22.50 × US$3.82 × US$62.32)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- US$39.80
- 53.29% below the price
US$2.39 (5-year average) ÷ 6%
Décio Bazin only bought shares yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years divided by 6%.
Graham ignores growth and debt; Bazin assumes past distributions will repeat. They are reference points for comparison, not a buy recommendation.
CVS indicators by year
Multiples at each year's closing price; margins and returns from that year's accounts.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 57.11 | 12.27 | 11.91 | 27.76 | 16.92 | 12.48 | 14.60 | -143.07 |
| P/B | 1.34 | 0.75 | 1.30 | 1.67 | 1.82 | 1.29 | 1.52 | 1.46 |
| EV/EBITDA | 9.75 | 3.80 | 4.88 | 8.54 | 7.61 | 4.29 | 9.62 | 22.53 |
| Dividend yield | 3.35% | 5.93% | 3.06% | 2.36% | 1.94% | 2.93% | 2.69% | 3.05% |
| Earnings per share | US$1.39 | US$3.66 | US$6.63 | US$3.36 | US$6.10 | US$5.47 | US$5.09 | -US$0.46 |
| Book value per share | US$59.12 | US$59.93 | US$60.76 | US$55.66 | US$56.79 | US$52.91 | US$48.97 | US$44.89 |
| ROE | 2.35% | 6.11% | 10.91% | 6.03% | 10.73% | 10.35% | 10.39% | -1.02% |
| ROIC | 5.83% | 9.23% | 15.74% | 10.58% | 13.54% | 17.52% | 7.11% | 0.00% |
| Gross margin | 44.99% | 44.67% | 39.32% | 38.94% | 39.82% | 38.97% | 38.19% | 19.32% |
| EBITDA margin | 2.30% | 3.52% | 5.06% | 3.78% | 6.09% | 6.83% | 6.37% | 3.48% |
| Net margin | 0.44% | 1.24% | 2.33% | 1.34% | 2.74% | 2.67% | 2.58% | -0.31% |
| Net debt/EBITDA | -1.14 | -0.52 | -0.61 | -1.29 | — | -0.59 | 3.69 | 9.92 |
CVS financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | US$402.1bn | US$372.8bn | US$357.8bn | US$322.5bn | US$292.1bn | US$268.7bn |
| Cost of sales | -US$221.2bn | -US$206.3bn | -US$217.1bn | -US$196.9bn | -US$175.8bn | -US$164bn |
| Gross profit | US$180.9bn | US$166.5bn | US$140.7bn | US$125.6bn | US$116.3bn | US$104.7bn |
| EBITDA | US$9.3bn | US$13.1bn | US$18.1bn | US$12.2bn | US$17.8bn | US$18.4bn |
| EBIT | US$4.7bn | US$8.5bn | US$13.7bn | US$8bn | US$13.3bn | US$13.9bn |
| Net finance result | — | — | — | — | — | — |
| Profit before tax | US$2.1bn | US$6.1bn | US$11.2bn | US$5.8bn | US$10.5bn | US$9.8bn |
| Income tax | -US$408m | -US$1.6bn | -US$2.8bn | -US$1.5bn | -US$2.5bn | -US$2.6bn |
| Net income | US$1.8bn | US$4.6bn | US$8.3bn | US$4.3bn | US$8bn | US$7.2bn |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does CVS pay dividends?
Dividend yield per year
- 2.76%2017
- 3.05%2018
- 2.69%2019
- 2.93%2020
- 1.94%2021
- 2.36%2022
- 3.06%2023
- 5.93%2024
- 3.35%2025
- 2.35%2026
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Dividend | 22/07/2026 | 03/08/2026 | US$0.67 |
| Dividend | 22/04/2026 | 04/05/2026 | US$0.67 |
| Dividend | 21/01/2026 | 02/02/2026 | US$0.67 |
| Dividend | 22/10/2025 | 03/11/2025 | US$0.67 |
| Dividend | 21/07/2025 | 01/08/2025 | US$0.67 |
| Dividend | 21/04/2025 | 01/05/2025 | US$0.67 |
| Dividend | 22/01/2025 | 03/02/2025 | US$0.67 |
| Dividend | 18/10/2024 | 01/11/2024 | US$0.67 |
| Dividend | 19/07/2024 | 01/08/2024 | US$0.67 |
| Dividend | 18/04/2024 | 01/05/2024 | US$0.67 |
| Dividend | 18/01/2024 | 01/02/2024 | US$0.67 |
| Dividend | 18/10/2023 | 01/11/2023 | US$0.61 |
See all 40 distributions
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Dividend | 19/07/2023 | 01/08/2023 | US$0.61 |
| Dividend | 19/04/2023 | 01/05/2023 | US$0.61 |
| Dividend | 18/01/2023 | 01/02/2023 | US$0.61 |
| Dividend | 19/10/2022 | 01/11/2022 | US$0.55 |
| Dividend | 20/07/2022 | 01/08/2022 | US$0.55 |
| Dividend | 20/04/2022 | 02/05/2022 | US$0.55 |
| Dividend | 19/01/2022 | 01/02/2022 | US$0.55 |
| Dividend | 20/10/2021 | 01/11/2021 | US$0.50 |
| Dividend | 21/07/2021 | 02/08/2021 | US$0.50 |
| Dividend | 21/04/2021 | 03/05/2021 | US$0.50 |
| Dividend | 20/01/2021 | 01/02/2021 | US$0.50 |
| Dividend | 20/10/2020 | 02/11/2020 | US$0.50 |
| Dividend | 21/07/2020 | 03/08/2020 | US$0.50 |
| Dividend | 21/04/2020 | 04/05/2020 | US$0.50 |
| Dividend | 21/01/2020 | 03/02/2020 | US$0.50 |
| Dividend | 22/10/2019 | 04/11/2019 | US$0.50 |
| Dividend | 23/07/2019 | 02/08/2019 | US$0.50 |
| Dividend | 19/04/2019 | 03/05/2019 | US$0.50 |
| Dividend | 23/01/2019 | 04/02/2019 | US$0.50 |
| Dividend | 22/10/2018 | 01/11/2018 | US$0.50 |
| Dividend | 23/07/2018 | 01/08/2018 | US$0.50 |
| Dividend | 19/04/2018 | 03/05/2018 | US$0.50 |
| Dividend | 22/01/2018 | 02/02/2018 | US$0.50 |
| Dividend | 20/10/2017 | 03/11/2017 | US$0.50 |
| Dividend | 19/07/2017 | 03/08/2017 | US$0.50 |
| Dividend | 18/04/2017 | 01/05/2017 | US$0.50 |
| Dividend | 19/01/2017 | 02/02/2017 | US$0.50 |
| Dividend | 19/10/2016 | 03/11/2016 | US$0.43 |
About Cvs Health
- Sector
- Retail
Questions about CVS
How much is CVS today?
CVS is at US$85.20 (-0.57% on the day), last traded on 01/10/2026.
How much did CVS pay in dividends in 2025?
CVS paid US$2.66 per share in 2025, a dividend yield of 3.35%.
What are the P/E and P/B of CVS?
CVS trades at a P/E of 22.28 and a P/B of 1.37.
How much did CVS return in 12 months?
CVS returned 11.45% in 12 months, with annualised volatility of 31.80% and a largest drawdown of -18.56%.